Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in bharat biotech

Bharat Biotech's Covaxin Now On UK's Approved Travel List

The Bharat Biotech manufactured Covaxin - the second most used formulation in India - had received its WHO EUL status, resulting in the UK announcing plans to include it on its list of approved COVID vaccines from November 22.

Read More

Covaxin 77.8% Effective Against COVID-19: Lancet Study

The efficacy analysis demonstrated that Covaxin to be 93.4 per cent effective against severe symptomatic Covid-19.

Read More

Bharat Biotech's Partner Ocugen Files EUA Request With FDA For Paediatric Use Of Covaxin

Having a new type of vaccine available will enable people to discuss with their child's physician the best approach for them to lower their child's risk of contracting COVID-19

Read More

'We Trust Indian Industry, Bharat Biotech Submitting Data Regularly, Very Quickly': WHO Official On Covaxin EUL

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the World Health Organisation on April 19 for the vaccine's Emergency Use Listing (EUL).

Read More

Bharat Biotech To Produce 700 Mn Covaxin Doses Annually

According to a press release issued by the Hyderabad-based vaccine maker, manufacturing scale-up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore.

Read More

SII Gets Nod To Send COVID Vaccines To Nepal, Bangladesh, Myanmar, Bulk To Astrazeneca; Bharat Biotech To Iran

SII has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month and has informed the Centre that it will be able to supply around 22 crore doses in October

Read More

WHO To Take Final Decision Next Week On Approval To Bharat Biotech's Covaxin

WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week, WHO said in a series of tweets.

Read More

Centre Got Over 65.25 Crore Covishield Doses, 9.1 Crore Covaxin Jabs Till September 19

The SII has informed the government that it will be able to supply around 22 crore doses of Covishield in October.

Read More

Decision On Bharat Biotech's Covaxin EUL In October: WHO

Submissions to WHO for prequalification or listing under the emergency use procedure are confidential. If a product submitted for assessment is found to meet the criteria for listing, the WHO will publish the results widely.

Read More

IIL To Make 10 Million Doses Of Covaxin Drug Substance From December

Lauding the efforts of the PSU for its ability to roll out the vaccine drug substance in record time, Union Minister Parshottam Rupala formally handed over the drug substance to Bharat Biotech, makers of Covaxin

Read More

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials

On the production levels of Covaxin, Ella said 100 million doses per month can be possible if the other manufacturing partners are fully geared up with safety and other parameters are in place.

Read More

Bharat Biotech Awaits Feedback From WHO For Covaxin Emergency Use Listing

As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on approval process and its timelines

Read More

ABB Commissions ACS560 Drives At Bharat Biotech''s Facility For Safe Manufacturing Of Covaxin

The drives are also installed at other pharmaceutical companies in India, which are manufacturing COVID-19 vaccines for the country

Read More

COVID-19 Update: Bharat Biotech Seeks International Partners To Produce More Vaccine

Bharat Biotech's COVAXIN does is already approved by the Union Government for emergency use in India. Meanwhile, it is one of two shots driving India's massive vaccination drive, amid the ongoing coronavirus pandemic.

Read More

Gujarat: First Commercial Batch Of Covaxin Released From Bharat Biotech's New Plant

The government had earlier this month given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.

Read More